n,n-carbonyldiimidazole has been researched along with warfarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hage, DS; Jiang, T; Mallik, R | 1 |
| Ameer, S; Fakhri, MI; Hussain, S; Khan, H; Khan, KM; Perveen, S; Salar, U; Tauseef, S; Wadood, A | 1 |
2 other study(ies) available for n,n-carbonyldiimidazole and warfarin
| Article | Year |
|---|---|
High-performance affinity monolith chromatography: development and evaluation of human serum albumin columns.
Topics: Carbonates; Chromatography, Affinity; Epoxy Compounds; Humans; Imidazoles; Methacrylates; Molecular Structure; Schiff Bases; Sensitivity and Specificity; Serum Albumin; Stereoisomerism; Succinimides; Time Factors; Tryptophan; Warfarin | 2004 |
1,1'-Carbonyldiimidazole (CDI) Mediated Facile Synthesis, Structural Characterization, Antimicrobial Activity, and in-silico Studies of Coumarin- 3-carboxamide Derivatives.
Topics: Amides; Anti-Bacterial Agents; Coumarins; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Imidazoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2018 |